Teladoc Health Reports Mixed Q4 & FY2025 Results, Projects Flat Revenue and Continued Losses for 2026

summarizeSummary

Teladoc Health reported mixed Q4 and Full Year 2025 results, with improved net loss driven by lower impairment charges, but flat to declining revenue and a struggling BetterHelp segment. The company issued a cautious 2026 outlook, projecting flat revenue and continued net losses.

check_boxKey Events

• Q4 2025 Financial Performance

  Fourth Quarter 2025 revenue was $642.3 million, flat year-over-year, with a net loss of $25.1 million (or $0.14 per share), an improvement from $48.4 million net loss in Q4 2024. Adjusted EBITDA increased 12% to $83.8 million.

• Full Year 2025 Financial Performance

  Full Year 2025 revenue decreased 2% to $2,530.0 million. Net loss significantly improved to $200.3 million (or $1.14 per share) from $1,001.2 million in Full Year 2024, primarily due to lower goodwill impairment charges. Adjusted EBITDA for the full year decreased 10% to $281.1 million.

• Segment Performance Divergence

  The Integrated Care segment saw revenue increase 5% in Q4 2025 and 3% for the full year. In contrast, the BetterHelp segment's revenue decreased 7% in Q4 and 9% for the full year, with its adjusted EBITDA declining 46% for the full year.

• Full Year 2026 Outlook

  The company projects Full Year 2026 revenue between $2,470 million and $2,587 million, adjusted EBITDA between $266 million and $308 million, and a net loss per share between $(1.10) and $(0.70), indicating continued unprofitability and largely flat revenue.

auto_awesomeAnalysis

Teladoc Health's latest earnings report presents a mixed financial picture. While the significant reduction in net loss for the full year 2025 is a positive, it was largely due to lower goodwill impairment charges rather than a substantial operational turnaround. Revenue growth remains stalled, with full-year revenue declining and Q4 revenue flat. The divergence in segment performance, with Integrated Care growing and BetterHelp experiencing notable declines, highlights internal challenges. The 2026 guidance, projecting flat revenue and continued net losses, suggests a path of stabilization rather than aggressive growth or a return to profitability in the near term. Investors will need to weigh the improved bottom line (due to reduced non-cash charges) against the ongoing top-line stagnation and segment-specific headwinds.